Publications
PopB-PcrV Interactions are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon.
Kundracik E.C., Trichka, J., Díaz Aponte, J.E., Roistacher, A., and Rietsch A.
mBio. 2022 Sep 26;e0238122. doi:10.1128/mbio.02381-22
The PopN Gate-keeper Complex Acts on the ATPase PscN to Regulate the T3SS Secretion Switch from Early to Middle Substrates in Pseudomonas aeruginosa.
Tuan-Dung Ngo, Caroline Perdu, Bakhos Jneid, Michel Ragno, Julia Novion Ducassou, Alexandra Kraut, Yohann Couté, Charles Stopford, Ina Attrée, Arne Rietsch, Eric Faudry
Journal of Molecular Biology. 2020. 432(24):166690
Cell-type specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system.
Armentrout, E.I., Kundracik E.C., and Rietsch A.
Mol Microbiol. 2021. 115(2):305-319. doi: 10.1111/mmi.14617
The structure of the Type III Secretion System export gate with CdsO, an ATPase lever arm.
Jensen, J.L., Yamini, S., Rietsch, A., and Spiller, B.W.
PLoS Pathogens. 2020. 16(10):e1008923
RNase E promotes expression of type III secretion system genes in Pseudomonas aeruginosa.
Josh. S. Sharp, Arne Rietsch, Simon L. Dove
Journal of Bacteriology. 2019. 201(22). pii: e00336-19.
Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
Vareechon C, Zmina SE, Karmakar M, Pearlman E, Rietsch A.
Cell host & microbe. 2017; 21(5):611-618.e5.
The Type III Secretion Translocation Pore Senses Host Cell Contact.
Armentrout EI, Rietsch A.
PLoS pathogens. 2016; 12(3):e1005530.
Control of type III secretion activity and substrate specificity by the cytoplasmic regulator PcrG.
Lee PC, Zmina SE, Stopford CM, Toska J, Rietsch A.
Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(19):E2027-36.
Toska J, Sun Y, Carbonell DA, Foster AN, Jacobs MR, Pearlman E, Rietsch A.
PloS one. 2014; 9(1):e86829.
Tomalka AG, Zmina SE, Stopford CM, Rietsch A.
Journal of bacteriology. 2013; 195(21):4836-43.
Karthikeyan RS, Priya JL, Leal SM Jr, Toska J, Rietsch A, Prajna V, Pearlman E, Lalitha P.
PloS one. 2013; 8(6):e64867.
Host defense at the ocular surface.
Pearlman E, Sun Y, Roy S, Karmakar M, Hise AG, Szczotka-Flynn L, Ghannoum M, Chinnery HR, McMenamin PG, Rietsch A.
International reviews of immunology. 2013; 32(1):4-18.
Tomalka AG, Stopford CM, Lee PC, Rietsch A.
Molecular microbiology. 2012; 86(6):1464-81.
Karmakar M, Sun Y, Hise AG, Rietsch A, Pearlman E.
Journal of immunology (Baltimore, Md. : 1950). 2012; 189(9):4231-5.
Sun Y, Karmakar M, Taylor PR, Rietsch A, Pearlman E.
Journal of immunology (Baltimore, Md. : 1950). 2012; 188(4):1884-95.
Sun Y, Karmakar M, Roy S, Ramadan RT, Williams SR, Howell S, Shive CL, Han Y, Stopford CM, Rietsch A, Pearlman E.
Journal of immunology (Baltimore, Md. : 1950). 2010; 185(7):4272-83.
Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV.
Lee PC, Stopford CM, Svenson AG, Rietsch A.
Molecular microbiology. 2010; 75(4):924-41.
ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa.
Cisz M, Lee PC, Rietsch A.
Journal of bacteriology. 2008; 190(8):2726-38.